Australia Small Molecule Innovator Cdmo Market Size & Outlook
Australia small molecule innovator cdmo market, 2018-2030 (US$M)
Related Markets
Australia small molecule innovator cdmo market highlights
- The Australia small molecule innovator cdmo market generated a revenue of USD 982.3 million in 2023 and is expected to reach USD 1,513.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, small molecule api was the largest revenue generating product in 2023.
- Small Molecule API is the most lucrative product segment registering the fastest growth during the forecast period.
Small molecule innovator cdmo market data book summary
| Market revenue in 2023 | USD 982.3 million |
| Market revenue in 2030 | USD 1,513.6 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule api |
| Fastest growing segment | Small Molecule API |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule API, Small Molecule Drug Product |
| Key market players worldwide | Wuxi AppTec Co Ltd, EQT Corp, Thermo Fisher Scientific Inc, Lonza Group Ltd, Catalent Inc, Siegfried Holding AG, Boehringer Ingelheim, Labcorp Holdings Inc, Piramal Pharma Solutions, CordenPharma, Cambrex |
Other key industry trends
- In terms of revenue, Australia accounted for 2.0% of the global small molecule innovator cdmo market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India small molecule innovator cdmo market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,881.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Small Molecule Innovator CDMO Market Scope
Small Molecule Innovator CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia small molecule innovator cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule innovator cdmo market will help companies and investors design strategic landscapes.
Small molecule api was the largest segment with a revenue share of 61.67% in 2023. Horizon Databook has segmented the Australia small molecule innovator cdmo market based on small molecule api, small molecule drug product covering the revenue growth of each sub-segment from 2018 to 2030.
The Australia small molecule innovator CDMO market is anticipated to grow at a moderate rate over the forecast period. Growth in the market can be attributed to the presence of multinational companies & their subsidiaries, superior clinical research & healthcare infrastructure, and skilled research capabilities.
Organizations all across the nation are setting up research facilities to support small molecule R&D, which is expected to expand the national market.
For example, in October 2023, Queensland University’s small molecule drug discovery facility welcomed researchers around Australia, owing to funding provided by the National Collaborative.
Reasons to subscribe to Australia small molecule innovator cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia small molecule innovator cdmo market databook
-
Our clientele includes a mix of small molecule innovator cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia small molecule innovator cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Australia small molecule innovator cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia small molecule innovator cdmo market size, by product, 2018-2030 (US$M)
Australia Small Molecule Innovator CDMO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
